You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 2, AUGUST 1939 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

EFFECT OF DIHYDROTACHYSTEROL IN TREATMENT OF PARATHYROID DEFICIENCY

EDWARD ROSE, M.D.; F. WILLIAM SUNDERMAN, M.D., Ph.D.

Arch Intern Med. 1939;64(2):217-227.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Tachysterol is one of several sterols derived from ergosterol by irradiation with ultraviolet light. Its relation to the other sterols can best be illustrated by the scheme modified by Bills1 from that of Setz:

Formula

Ergosterol Lumisterol Tachysterol Calciferol (vitamin D) Substance 248 (Toxisterol) Suprasterol I Suprasterol II Experimentally tachysterol has been found to cause an increase in absorption and urinary excretion of calcium, and a rise in the concentration of calcium in the serum. There is no evidence that parathyroid function is affected. An orally effective derivative, dihydrotachysterol (antitetanic preparation no. 10, or "A. T. 10"), was first used in the treatment of parathyroid tetany by Holtz,2 in Germany, in 1933. Since then it has been extensively used, chiefly in Germany, and its effects have been reported on in considerable detail. The literature has recently been reviewed by Albright and his associates.3 Fromtheir review the principal data concerning dihydrotachysterol may . . . [Full Text PDF of this Article]


Author Affiliations

PHILADELPHIA

From the William Pepper Laboratory of Clinical Medicine, the Endocrine Section of the Medical Clinic and the Department of Research Medicine, Hospital of the University of Pennsylvania.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1939 American Medical Association. All Rights Reserved.